Bioventa is open for business

I have spent my career in diagnostics and medtech, working across commercial strategy, market access, and organisational leadership. I have sat in the rooms where plans get made, where teams get built under pressure, and where the distance between scientific promise and commercial reality becomes uncomfortably clear.

That distance is not inevitable. It is a choice — usually made by default, when companies focus on the science they are rightly proud of and treat commercialisation as something to sort out later.

It rarely works. And it costs far more than the price of getting it right early.

Bioventa exists for the companies that are ready to take that seriously.

We work with life science companies — primarily in medical devices, diagnostics, and biotech platform technologies — at the moments that matter most: building commercial teams, shaping go-to-market strategy, navigating complex buyer landscapes, and preparing organisations for growth.

This is not generalist consulting. It is bespoke, senior-level engagement from someone who has done the work, made the calls, and understands that every commercial challenge in this industry is also a scientific, organisational, and human one.

I started Bioventa because I believe that the gap between great science and successful commercialisation is closeable. Not with frameworks off a slide, but with clear thinking, honest assessment, and the kind of commercial discipline that turns a product with genuine potential into one that actually reaches the people who need it.

If you are building a commercial team, preparing for a launch, or working through a market entry strategy and you want a thinking partner who will engage with the real complexity of your situation, I would be glad to have that conversation.

Bioventa works with a select number of clients at any time. If you would like to explore whether we are the right fit for your challenge, reach out directly via our contact page.